FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2126088650> ?p ?o ?g. }

• W2126088650 abstract "The growing possibilities of cancer prevention and treatment as well as the increasing knowledge about hereditary cancers require proper identification of the persons at risk. The aim of this study was to test the outcome of population screening in the scientific and practical evaluation of hereditary cancer.Population screening for hereditary cancer was carried out retrospectively in a geographic area of Latvia. Family cancer histories were collected from 18642 adults representing 76.6% of the population of this area. Hereditary cancer syndromes were diagnosed clinically. Molecular testing for BRCA1 founder mutations 300 T/G, 4153delA and 5382insC was conducted in 588 persons who reported at least one case of breast or ovary cancer among blood relatives.Clinically, 74 (0.40%; 95% confidence interval (CI): 0.32 - 0.50%) high-risk and 548 (2.94%, 95% CI: 2.71 - 3.19) moderate-risk hereditary cancer syndromes were detected covering wide cancer spectrum. All syndromes were characterised by high cancer frequency among blood relatives ranging 8.6 - 46.2% in contrast to spouse correlation of 2.5 - 3.6%. The mean age of cancer onset ranged 38.0 - 72.0 years in different syndromes. The BRCA1 gene mutations were identified in 10 (1.7%; 95% CI: 0.9 - 3.1%) probands. Families with established BRCA1 gene founder mutations were identified with the frequency 1:2663 clinically screened persons.Population screening is a useful practical tool for the identification of persons belonging to families with high frequency of malignant tumours. The whole hereditary and familial cancer spectrum along with the age structure was identified adjusting follow-up guidelines. Another benefit of the population screening is the possibility to identify oncologically healthy persons belonging to hereditary and familial cancer families so that appropriate surveillance can be offered. Clinical diagnostics is appropriate for population screening purposes; molecular investigation provides additional information. In collaboration with family doctors, the screening is technically manageable as characterised by high compliance." @default.
• W2126088650 created "2016-06-24" @default.
• W2126088650 creator A5004837648 @default.
• W2126088650 creator A5005207314 @default.
• W2126088650 creator A5013239155 @default.
• W2126088650 creator A5018054072 @default.
• W2126088650 creator A5055875311 @default.
• W2126088650 creator A5057252376 @default.
• W2126088650 creator A5072176733 @default.
• W2126088650 creator A5077152126 @default.
• W2126088650 creator A5081450529 @default.
• W2126088650 date "2010-10-29" @default.
• W2126088650 modified "2023-10-14" @default.
• W2126088650 title "Population screening for hereditary and familial cancer syndromes in Valka district of Latvia" @default.
• W2126088650 cites W1494943394 @default.
• W2126088650 cites W1588813253 @default.
• W2126088650 cites W1599233918 @default.
• W2126088650 cites W1967613350 @default.
• W2126088650 cites W1969927247 @default.
• W2126088650 cites W1970663082 @default.
• W2126088650 cites W1976674343 @default.
• W2126088650 cites W2000765979 @default.
• W2126088650 cites W2008171718 @default.
• W2126088650 cites W2010911652 @default.
• W2126088650 cites W2011409548 @default.
• W2126088650 cites W2017784546 @default.
• W2126088650 cites W2045667568 @default.
• W2126088650 cites W2056297572 @default.
• W2126088650 cites W2056727381 @default.
• W2126088650 cites W2062305215 @default.
• W2126088650 cites W2066870000 @default.
• W2126088650 cites W2082500137 @default.
• W2126088650 cites W2092158263 @default.
• W2126088650 cites W2098948163 @default.
• W2126088650 cites W2099802436 @default.
• W2126088650 cites W2109235789 @default.
• W2126088650 cites W2113382133 @default.
• W2126088650 cites W2117771986 @default.
• W2126088650 cites W2134291977 @default.
• W2126088650 cites W2140847299 @default.
• W2126088650 cites W2146717458 @default.
• W2126088650 cites W2148002226 @default.
• W2126088650 cites W2153883696 @default.
• W2126088650 cites W2164667084 @default.
• W2126088650 cites W4234236664 @default.
• W2126088650 cites W79026712 @default.
• W2126088650 doi "https://doi.org/10.1186/1897-4287-8-8" @default.
• W2126088650 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2978132" @default.
• W2126088650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21034437" @default.
• W2126088650 hasPublicationYear "2010" @default.
• W2126088650 type Work @default.
• W2126088650 sameAs 2126088650 @default.
• W2126088650 citedByCount "9" @default.
• W2126088650 countsByYear W21260886502013 @default.
• W2126088650 countsByYear W21260886502014 @default.
• W2126088650 countsByYear W21260886502015 @default.
• W2126088650 countsByYear W21260886502017 @default.
• W2126088650 countsByYear W21260886502019 @default.
• W2126088650 countsByYear W21260886502020 @default.
• W2126088650 countsByYear W21260886502021 @default.
• W2126088650 crossrefType "journal-article" @default.
• W2126088650 hasAuthorship W2126088650A5004837648 @default.
• W2126088650 hasAuthorship W2126088650A5005207314 @default.
• W2126088650 hasAuthorship W2126088650A5013239155 @default.
• W2126088650 hasAuthorship W2126088650A5018054072 @default.
• W2126088650 hasAuthorship W2126088650A5055875311 @default.
• W2126088650 hasAuthorship W2126088650A5057252376 @default.
• W2126088650 hasAuthorship W2126088650A5072176733 @default.
• W2126088650 hasAuthorship W2126088650A5077152126 @default.
• W2126088650 hasAuthorship W2126088650A5081450529 @default.
• W2126088650 hasBestOaLocation W21260886501 @default.
• W2126088650 hasConcept C104317684 @default.
• W2126088650 hasConcept C121608353 @default.
• W2126088650 hasConcept C126322002 @default.
• W2126088650 hasConcept C143998085 @default.
• W2126088650 hasConcept C188997412 @default.
• W2126088650 hasConcept C2780673598 @default.
• W2126088650 hasConcept C2781179581 @default.
• W2126088650 hasConcept C2908647359 @default.
• W2126088650 hasConcept C47042493 @default.
• W2126088650 hasConcept C501734568 @default.
• W2126088650 hasConcept C530470458 @default.
• W2126088650 hasConcept C54355233 @default.
• W2126088650 hasConcept C71924100 @default.
• W2126088650 hasConcept C86803240 @default.
• W2126088650 hasConcept C99454951 @default.
• W2126088650 hasConceptScore W2126088650C104317684 @default.
• W2126088650 hasConceptScore W2126088650C121608353 @default.
• W2126088650 hasConceptScore W2126088650C126322002 @default.
• W2126088650 hasConceptScore W2126088650C143998085 @default.
• W2126088650 hasConceptScore W2126088650C188997412 @default.
• W2126088650 hasConceptScore W2126088650C2780673598 @default.
• W2126088650 hasConceptScore W2126088650C2781179581 @default.
• W2126088650 hasConceptScore W2126088650C2908647359 @default.
• W2126088650 hasConceptScore W2126088650C47042493 @default.
• W2126088650 hasConceptScore W2126088650C501734568 @default.
• W2126088650 hasConceptScore W2126088650C530470458 @default.
• W2126088650 hasConceptScore W2126088650C54355233 @default.
• W2126088650 hasConceptScore W2126088650C71924100 @default.
• W2126088650 hasConceptScore W2126088650C86803240 @default.

• next